The Chemours Company
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $671.0M | $563.0M | $670.0M | $613.0M | $502.0M | $464.0M | $713.0M | $596.0M |
| Accounts Receivable | $773.0M | $645.0M | $562.0M | $817.0M | $813.0M | $704.0M | $619.0M | $825.0M |
| Inventory | $1.45B | $1.54B | $1.57B | $1.55B | $1.56B | $1.55B | $1.46B | $1.43B |
| Total Current Assets | $3.09B | $2.93B | $3.00B | $3.21B | $3.10B | $2.93B | $3.02B | $3.08B |
| Property, Plant & Equipment | $3.03B | $3.04B | $3.08B | $3.10B | $3.13B | $3.14B | $3.19B | $3.17B |
| Goodwill | $46.0M | $46.0M | $46.0M | $46.0M | $46.0M | $46.0M | $46.0M | $46.0M |
| Intangible Assets (Excl. Goodwill) | — | — | $2.0M | $2.0M | — | — | $3.0M | $3.0M |
| Total Assets | $7.15B | $7.27B | $7.38B | $7.55B | $7.46B | $7.38B | $7.51B | $7.46B |
| Liabilities | ||||||||
| Accounts Payable | $937.0M | $891.0M | $954.0M | $1.04B | $1.02B | $1.01B | $1.16B | $1.08B |
| Total Current Liabilities | $1.86B | $1.61B | $1.69B | $1.87B | $1.83B | $1.67B | $1.82B | $1.79B |
| Long-Term Debt | $3.84B | $4.10B | $4.10B | $4.10B | $4.11B | $4.07B | $4.06B | $3.99B |
| Total Liabilities | $7.20B | $7.05B | $7.13B | $7.27B | $7.23B | $6.81B | $6.94B | $6.81B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $891.0M | $1.18B | $1.22B | $1.28B | $1.25B | $1.64B | $1.69B | $1.75B |
| Total Stockholders' Equity | $-49.0M | $215.0M | $250.0M | $274.0M | $228.0M | $566.0M | $571.0M | $643.0M |